Perspective Therapeutics (CATX) Enterprise Value Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -28.72%
Dec 31, 2025 36.22%
Sep 30, 2025 43.68%
Jun 30, 2025 -20.99%
Mar 31, 2025 -109.80%
Dec 31, 2024 -2,356.33%
Sep 30, 2024 -1,619.42%
Jun 30, 2024 -934.18%
Mar 31, 2024 -395.58%
Dec 31, 2023 78.89%
Sep 30, 2023 66.77%
Jun 30, 2023 49.33%
Mar 31, 2023 38.12%
Dec 31, 2022 27.50%
Sep 30, 2022 12.28%
Jun 30, 2022 12.44%
Mar 31, 2022 9.16%
Dec 31, 2021 -529.67%
Sep 30, 2021 -3,079.90%
Jun 30, 2021 -2,568.39%
Mar 31, 2021 -2,596.09%
Dec 31, 2020 -201.42%
Sep 30, 2020 57.60%
Jun 30, 2020 55.09%
Mar 31, 2020 62.37%
Dec 31, 2019 59.58%
Sep 30, 2019 50.23%
Jun 30, 2019 -55.50%
Mar 31, 2019 -41.57%
Dec 31, 2018 -38.62%
Sep 30, 2018 -26.70%
Jun 30, 2018 61.82%
Mar 31, 2018 56.62%
Dec 31, 2017 52.49%
Sep 30, 2017 47.07%
Jun 30, 2017 27.57%
Mar 31, 2017 10.32%
Dec 31, 2016 5.16%
Sep 30, 2016 -763.22%
Jun 30, 2016 15.10%
Mar 31, 2016 -976.98%
Dec 31, 2015 -842.33%
Jun 30, 2015 17.49%
Mar 31, 2015 95.45%
Dec 31, 2014 69.72%
Jun 30, 2014 -509.77%
Mar 31, 2014 -543.36%
Dec 31, 2013 0.59%
Sep 30, 2013 -5.08%
Jun 30, 2013 -8.50%
Mar 31, 2013 -45.94%
Dec 31, 2012 -29.24%
Sep 30, 2012 -215.37%
Jun 30, 2012 -26.53%
Mar 31, 2012 27.37%
Dec 31, 2011 -24.03%
Sep 30, 2011 -55.63%